OSUR
$11.29
Orasure Tech
$.73
6.91%
OSUR
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  $0.04
Revenue:  $56.69 Mil
Tuesday
Aug 3
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when OSUR reports earnings?
Beat
Meet
Miss

Where is OSUR's stock price going from here?
Up
Flat
Down
Stock chart of OSUR
Analysts
Summary of analysts' recommendations for OSUR
Score
Grade
Pivots
Resistance
$12.29
$11.82
$11.55

$11.08

Support
$10.81
$10.34
$10.07
Tweet
Growth
Description
OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices.
Peers
StrykerBoston ScientificAbbottBaxter InternationalBecton, DickinsonResMedWaters3MCardiovascular SystemsMerit Medical Systems